Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Cash (2016 - 2025)

Standard Biotools (LAB) has disclosed Change in Cash for 16 consecutive years, with -$8.7 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 79.8% to -$8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$45.5 million through Dec 2025, down 139.14% year-over-year, with the annual reading at -$45.5 million for FY2025, 139.14% down from the prior year.
  • Change in Cash for Q4 2025 was -$8.7 million at Standard Biotools, up from -$29.2 million in the prior quarter.
  • The five-year high for Change in Cash was $235.8 million in Q1 2024, with the low at -$62.6 million in Q3 2023.
  • Average Change in Cash over 5 years is -$95526.3, with a median of -$15.3 million recorded in 2025.
  • The sharpest move saw Change in Cash tumbled 572.31% in 2021, then surged 1997.52% in 2023.
  • Over 5 years, Change in Cash stood at -$39.2 million in 2021, then surged by 153.83% to $21.1 million in 2022, then plummeted by 232.41% to -$28.0 million in 2023, then crashed by 54.27% to -$43.1 million in 2024, then surged by 79.8% to -$8.7 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$8.7 million, -$29.2 million, and $7.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.